# SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

> **NCT04470934** · — · ACTIVE_NOT_RECRUITING · sponsor: **B. Braun Melsungen AG** · enrollment: 1302 (estimated)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischaemia

## Interventions

- **DEVICE:** SeQuent® SCB drug-coated balloon catheter

## Key facts

- **NCT ID:** NCT04470934
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-30
- **Primary completion:** 2026-01-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 1302 (ESTIMATED)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04470934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04470934, "SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04470934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*